Compare Eli Lilly And Co (LLY) vs SP Funds S&P 500 Sharia Industry Exclusions ETF (SPUS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Eli Lilly And Co vs SP Funds S&P 500 Sharia Industry Exclusions ETF — how do they compare? Eli Lilly And Co trades at $1,175.96 (market cap $1.02T), while SP Funds S&P 500 Sharia Industry Exclusions ETF trades at $57.05. The key difference: Eli Lilly And Co pays a 0.6% dividend while SP Funds S&P 500 Sharia Industry Exclusions ETF pays none. Which is the better fit depends on your goals.
| LLY | SPUS | |
|---|---|---|
Market Cap | $1.02T | — |
Sector | Health | Broad Market / Factor |
52-Week High | $1.24K | $59.51 |
52-Week Low | $625.65 | $45.32 |
Enterprise Value | $1.06T | — |
Dividend Yield | 0.6% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Eli Lilly (LLY) trades at $1,175.15, down 0.33% on the day, with a bullish technical signal and strong fundamental momentum. Revenue surged to $65.18B in 2025, with net income reaching $20.64B, and the company has beaten earnings estimates for three consecutive quarters. Recent news includes a lawsuit from Novo Nordisk over weight-loss drug advertising, but analyst sentiment remains overwhelmingly positive with a $1,380 consensus price target.
Outlook is supported by robust earnings growth and high profitability margins, but risks include competitive pressures and elevated valuation multiples. The stock's current price is near key resistance at $1,174, with institutional buying activity indicating continued confidence in Lilly's growth trajectory in the pharmaceutical sector.
SPUS trades at $57.07, up 1.1% today, with a bearish technical signal from moving averages. The stock exhibits a consistent dividend payout pattern, with recent quarterly dividends of $0.03. Support and resistance levels suggest near-term price consolidation. Financial ratios are not available in the provided data.
The outlook for SPUS is mixed, with technical weakness offset by dividend stability. Risks include broader market volatility and reliance on dividend strategies. Upside potential hinges on sustained profitability and positive earnings momentum.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Eli Lilly And Co
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →About SP Funds S&P 500 Sharia Industry Exclusions ETF
SPUS tracks a market-cap weighted index of S&P 500 stocks that adhere to Sharia law. It screens out companies involved in non-compliant business activities such as alcohol, tobacco, gambling, and conventional finance, as well as excluding sectors like Aerospace & Defense, and Data Processing. By focusing on low-leverage stocks, SPUS provides investors with a value-conscious, ethically-aligned exposure to a diversified portfolio of large-cap U.S. equities.
Read more on SPUS →
